title: Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?
authors.affiliation: The Paterson Institute for Cancer Research, Wilmslow Rd, Manchester, UK.
authors.forename: Matthew
authors.initials: M
authors.lastname: Martin
authors.forename: Richard
authors.initials: R
authors.lastname: Marais
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D017024:Chemotherapy, Adjuvant; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D007004:Hypoglycemic Agents; D008687:Metformin; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases